Letter: Drug interaction in resmetirom times

LINKED CONTENT This article is linked to Harrison et al paper. To view this article, visit https://doi.org/10.1111/apt.17734

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 60; no. 4; pp. 533 - 534
Main Authors Zhou, Xiao‐Dong, Liu, Wen‐Yue, Targher, Giovanni, Byrne, Christopher D., Zheng, Ming‐Hua
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.08.2024
Subjects
Drug interaction
Drug Interactions
Humans
Online AccessGet full text

Cover

Abstract LINKED CONTENT This article is linked to Harrison et al paper. To view this article, visit https://doi.org/10.1111/apt.17734
AbstractList This article is linked to Harrison et al paper. To view this article, visit https://doi.org/10.1111/apt.17734
LINKED CONTENT This article is linked to Harrison et al paper. To view this article, visit https://doi.org/10.1111/apt.17734
Author Zhou, Xiao‐Dong
Targher, Giovanni
Liu, Wen‐Yue
Byrne, Christopher D.
Zheng, Ming‐Hua
Author_xml – sequence: 1
  givenname: Xiao‐Dong
  surname: Zhou
  fullname: Zhou, Xiao‐Dong
  organization: The Heart Center, the First Affiliated Hospital of Wenzhou Medical University
– sequence: 2
  givenname: Wen‐Yue
  surname: Liu
  fullname: Liu, Wen‐Yue
  organization: The First Affiliated Hospital of Wenzhou Medical University
– sequence: 3
  givenname: Giovanni
  orcidid: 0000-0002-4325-3900
  surname: Targher
  fullname: Targher, Giovanni
  organization: IRCCS Sacro Cuore—Don Calabria Hospital
– sequence: 4
  givenname: Christopher D.
  surname: Byrne
  fullname: Byrne, Christopher D.
  organization: Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton, and University of Southampton, Southampton General Hospital
– sequence: 5
  givenname: Ming‐Hua
  orcidid: 0000-0003-4984-2631
  surname: Zheng
  fullname: Zheng, Ming‐Hua
  email: zhengmh@wmu.edu.cn
  organization: Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39014902$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1LAzEQhoNU7Ice_ANS8KLgtpNMN9n1VuonFPTQe0h3E0nZj5pkkf57d231IOhcZg7P-zI8Q9Kr6koTck5hQtuZqm2Y0AQ4OyIDijyOGCDvkQEwnkYsodgnQ-83AMAFsBPSxxToLAU2IDdLHYJ2t-M717yNbdXeKgu2rtp77LQvdbCuLsfBltqfkmOjCq_PDntEVg_3q8VTtHx5fF7Ml1GGMbIozpI8QRoDroWBeCbyWW5ioKniOePIjWAm1blBw1WMuE4AGICABLkWeYojcrWv3br6vdE-yNL6TBeFqnTdeImQUCEwFXGLXv5CN3Xjqva5jkLEhEJXeHGgmnWpc7l1tlRuJ781tMD1Hshc7b3T5gehIDvFslUsvxS37PQXm9mgOmXBKVv8l_iwhd79XS3nr6t94hMk24jx
CitedBy_id crossref_primary_10_3390_cimb47030154
crossref_primary_10_1097_CP9_0000000000000106
Cites_doi 10.1016/j.ejmech.2019.112006
10.1056/NEJMoa2309000
10.1016/j.metabol.2024.155835
10.1111/apt.17734
10.1038/s41591‐023‐02603‐1
10.1007/s12072‐023‐10543‐8
10.1136/gutjnl‐2023‐330596
ContentType Journal Article
Copyright 2024 John Wiley & Sons Ltd.
Copyright © 2024 John Wiley & Sons Ltd.
Copyright_xml – notice: 2024 John Wiley & Sons Ltd.
– notice: Copyright © 2024 John Wiley & Sons Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7U9
H94
K9.
M7N
7X8
DOI 10.1111/apt.18062
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2036
EndPage 534
ExternalDocumentID 39014902
10_1111_apt_18062
APT18062
Genre correspondence
Letter
Commentary
Editorial
Correspondence
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YOC
ZZTAW
~IA
~WT
AAYXX
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
M7N
7X8
ID FETCH-LOGICAL-c3532-5c8d831503b7f0547d4df5019a6d2636f72f9edf3f6a533b80020070836e7d93
IEDL.DBID DR2
ISSN 0269-2813
1365-2036
IngestDate Fri Jul 11 09:12:44 EDT 2025
Wed Aug 13 08:30:48 EDT 2025
Wed Feb 19 02:04:25 EST 2025
Thu Apr 24 22:52:25 EDT 2025
Tue Jul 01 02:22:43 EDT 2025
Wed Jan 22 17:17:38 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3532-5c8d831503b7f0547d4df5019a6d2636f72f9edf3f6a533b80020070836e7d93
Notes SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ObjectType-Correspondence-1
ORCID 0000-0003-4984-2631
0000-0002-4325-3900
PMID 39014902
PQID 3083338109
PQPubID 2045200
PageCount 2
ParticipantIDs proquest_miscellaneous_3081773975
proquest_journals_3083338109
pubmed_primary_39014902
crossref_primary_10_1111_apt_18062
crossref_citationtrail_10_1111_apt_18062
wiley_primary_10_1111_apt_18062_APT18062
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2024
2024-08-00
2024-Aug
20240801
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: August 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle Alimentary pharmacology & therapeutics
PublicationTitleAlternate Aliment Pharmacol Ther
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2024; 73
2024; 154
2020; 188
2023; 17
2024; 59
2023; 29
2024; 390
e_1_2_3_2_1
e_1_2_3_6_1
e_1_2_3_5_1
e_1_2_3_4_1
e_1_2_3_3_1
e_1_2_3_8_1
e_1_2_3_7_1
References_xml – volume: 188
  year: 2020
  article-title: Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME‐toxicity analysis
  publication-title: Eur J Med Chem
– volume: 29
  start-page: 2919
  year: 2023
  end-page: 2928
  article-title: Resmetirom for nonalcoholic fatty liver disease: a randomized, double‐blind, placebo‐controlled phase 3 trial
  publication-title: Nat Med
– volume: 59
  start-page: 51
  year: 2024
  end-page: 63
  article-title: Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis
  publication-title: Aliment Pharmacol Ther
– volume: 390
  start-page: 497
  year: 2024
  end-page: 509
  article-title: A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis
  publication-title: N Engl J Med
– volume: 154
  year: 2024
  article-title: Resmetirom, the first approved drug for the management of metabolic dysfunction‐associated steatohepatitis: trials, opportunities, and challenges
  publication-title: Metabolism
– volume: 73
  start-page: 573
  year: 2024
  end-page: 581
  article-title: Thyroid hormone receptor‐beta agonists: new MASLD therapies on the horizon
  publication-title: Gut
– volume: 17
  start-page: 773
  year: 2023
  end-page: 791
  article-title: An international multidisciplinary consensus statement on MAFLD and the risk of CVD
  publication-title: Hepatol Int
– ident: e_1_2_3_4_1
  doi: 10.1016/j.ejmech.2019.112006
– ident: e_1_2_3_5_1
  doi: 10.1056/NEJMoa2309000
– ident: e_1_2_3_7_1
  doi: 10.1016/j.metabol.2024.155835
– ident: e_1_2_3_2_1
  doi: 10.1111/apt.17734
– ident: e_1_2_3_6_1
  doi: 10.1038/s41591‐023‐02603‐1
– ident: e_1_2_3_8_1
  doi: 10.1007/s12072‐023‐10543‐8
– ident: e_1_2_3_3_1
  doi: 10.1136/gutjnl‐2023‐330596
SSID ssj0006702
Score 2.4553134
Snippet LINKED CONTENT This article is linked to Harrison et al paper. To view this article, visit https://doi.org/10.1111/apt.17734
This article is linked to Harrison et al paper. To view this article, visit https://doi.org/10.1111/apt.17734
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 533
SubjectTerms Drug interaction
Drug Interactions
Humans
Title Letter: Drug interaction in resmetirom times
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.18062
https://www.ncbi.nlm.nih.gov/pubmed/39014902
https://www.proquest.com/docview/3083338109
https://www.proquest.com/docview/3081773975
Volume 60
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED_GBPHF74_plCo--GDH1rRpo0-bOoYwEZngg1CSJhFRN9m6F_96L-mHzg8Q3wK9Nk0ul_wuufsF4FAx7mktuKsSzV2fKeoKFQVuoozpIWbW1OQO969o79a_vAvuKnBa5MJk_BDlhpuxDDtfGwPnYvLJyPlr2mhFTTv_mlgtA4huPqijaGjjDdHFYK4XtUjOKmSieMo3Z9eibwBzFq_aBae7BPfFr2ZxJk-NaSoaydsXFsd_tmUZFnMg6rSzkbMCFTVchfl-ftS-BsdZos-Jcz6ePjiGVWKc5UBg2UEf_UWlj-PRi2Mvp1-HQfdicNZz86sV3IQEBN3PJJIRQTBIRKgRtYXSlzpAuMep9CihOvQ0U1ITVBUCQmFhJc4OEaEqlIxsQHU4GqotcEIe0ARhn2EW9EVTMMaJ1gmRkhItm7QGR0Ufx0lOO25uv3iOC_cDGx_bxtfgoBR9zbg2fhKqF4qKc3ObxFg5IYarjNVgv3yMhmJOP_hQjaZWphWGCL-CGmxmCi5rMRs_Pmvix4-smn6vPm5fD2xh---iO7DgIRTKwgbrUE3HU7WLUCYVezDX7px3unt27L4DpjvuCQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLYmkIAL78dgQEEcdqDT1rRpg7hMjGnANiE0pF1Q1TYJQrCHRnfh1-OkDxgPCXGrVLdp6jj5nNifAU4ECywpw8AUkQxMmwlqhsJzzEgo00PMLKnKHe50aevevu47_QKcZ7kwCT9EvuGmLEPP18rA1Yb0JysPxnGl5lXVBDyvKnor5vzG3Qd5FHV1xCE6Gcy0vBpJeYVUHE_-6Oxq9A1iziJWveQ0V-Ah-9gk0uS5Mo3DSvT2hcfxv71ZheUUixr1ZPCsQUEM12Ghk562b8BpkutzZjQm00dDEUtMkjQIvDbQTR-I-GkyGhi6Pv0m9JqXvYuWmVZXMCPiEPRAI497BPEgCV2JwM3lNpcOIr6AcosSKl1LMsElQW0hJgw1ssQJwiNUuJyRLZgbjoZiBww3cGiEyE-RC9phNWQsIFJGhHNKJK_SIpSzn-xHKfO4KoDx4mceCHbe150vwnEuOk7oNn4SKmWa8lOLe_WxcUIUXRkrwlF-G21FHYAEQzGaapma6yICc4qwnWg4b0Xt_disii8vaz393rxfv-3pi92_ix7CYqvXafvtq-7NHixZiIySKMISzMWTqdhHZBOHB3oAvwMQvvCz
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB6KQvHi-1GfUTz0YEqaTTZZPRVrqU-KVOhBCEl2V0RtS0wv_npnNw-tDxBvgUyy2czO7je7M98AHAoW2lJGoSliGZoOE9SMhO-asVCmh5hZUpU7fH1Du3fOxcAdVOCkyIXJ-CHKDTdlGXq-VgY-5vKTkYfjtNH0LTX_zjrUYqpuQ_v2gzuKejrgEH0MZtp-k-S0QiqMp3x0ejH6hjCnAatecToLcF98axZo8tSYpFEjfvtC4_jPzizCfI5EjVY2dJagIobLUL3Oz9pX4CjL9Dk22snkwVC0EkmWBIHXBjrpLyJ9TEYvhq5Ovwr9zln_tGvmtRXMmLgE_c_Y5z5BNEgiTyJs87jDpYt4L6TcpoRKz5ZMcElQV4gII40rcXrwCRUeZ2QNZoajodgAwwtdGiPuU9SCTmRFjIVEyphwTonkFq1BvfjHQZzzjqvyF89B4X9g5wPd-RoclKLjjGzjJ6HtQlFBbm-vATZOiCIrYzXYL2-jpajjj3AoRhMt0_Q8xF9uDdYzBZetqJ0fh1n48rpW0-_NB61eX19s_l10D6q9die4Or-53II5G2FRFkK4DTNpMhE7CGvSaFcP33dITO9i
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Letter%3A+Drug+interaction+in+resmetirom+times&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Zhou%2C+Xiao%E2%80%90Dong&rft.au=Liu%2C+Wen%E2%80%90Yue&rft.au=Targher%2C+Giovanni&rft.au=Byrne%2C+Christopher+D.&rft.date=2024-08-01&rft.issn=0269-2813&rft.eissn=1365-2036&rft.volume=60&rft.issue=4&rft.spage=533&rft.epage=534&rft_id=info:doi/10.1111%2Fapt.18062&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_apt_18062
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon